Glutamine-containing dipeptides in parenteral nutrition

Area of Science:

• Biochemistry
• Clinical Nutrition
• Metabolic Research

Background:

• Glutamine constitutes 60% of intracellular amino acids and is significantly depleted during catabolic stress.
• This depletion is difficult to reverse with conventional therapies, impacting muscle protein conservation.
• Glutamine's instability and poor solubility limit its use in parenteral nutrition.

Purpose of the Study:

• To evaluate the efficacy of a stable glutamine-containing dipeptide, L-alanyl-L-glutamine (Ala-Gln), in parenteral nutrition.
• To determine if Ala-Gln can maintain intracellular glutamine levels and improve nitrogen balance in catabolic patients.

Main Methods:

• In vivo studies in humans and animals demonstrated Ala-Gln hydrolysis after intravenous administration.
• Clinical trials compared parenteral nutrition with and without Ala-Gln supplementation in catabolic patients.
• Measurements included nitrogen balance and muscle glutamine concentrations.

Main Results:

• Ala-Gln was shown to be a safe and effective source of glutamine in parenteral nutrition.
• Patients receiving Ala-Gln supplementation exhibited more positive nitrogen balance compared to controls.
• Muscle glutamine concentrations were maintained in postoperative trauma patients supplemented with Ala-Gln.

Conclusions:

• Catabolic stress increases demand for glutamine, leading to muscle glutamine depletion.
• Supplementation with Ala-Gln in parenteral nutrition can preserve the muscle glutamine pool and enhance nitrogen economy.
• Adequate glutamine delivery is essential for maintaining intestinal integrity and supporting rapidly proliferating cells during stress.